27 research outputs found
Non-pharmacological treatment for depressed older patients in primary care: A systematic review and meta-analysis
Contains fulltext :
177843.pdf (publisher's version ) (Open Access)BACKGROUND: Late-life depression is most often treated in primary care, and it usually coincides with chronic somatic diseases. Given that antidepressants contribute to polypharmacy in these patients, and potentially to interactions with other drugs, non-pharmacological treatments are essential. In this systematic review and meta-analysis, we aimed to present an overview of the non-pharmacological treatments available in primary care for late-life depression. METHOD: The databases of PubMed, PsychINFO, and the Cochrane Central Register of Controlled Trials were systematically searched in January 2017 with combinations of MeSH-terms and free text words for "general practice," "older adults," "depression," and "non-pharmacological treatment". All studies with empirical data concerning adults aged 60 years or older were included, and the results were stratified by primary care, and community setting. We narratively reviewed the results and performed a meta-analysis on cognitive behavioral therapy in the primary care setting. RESULTS: We included 11 studies conducted in primary care, which covered the following five treatment modalities: cognitive behavioral therapy, exercise, problem-solving therapy, behavioral activation, and bright-light therapy. Overall, the meta-analysis showed a small effect for cognitive behavioral therapy, with one study also showing that bright-light therapy was effective. Another 18 studies, which evaluated potential non-pharmacological interventions in the community suitable for implementation, indicated that bibliotherapy, life-review, problem-solving therapy, and cognitive behavioral therapy were effective at short-term follow-up. DISCUSSION: We conclude that the effects of several treatments are promising, but need to be replicated before they can be implemented more widely in primary care. Although more treatment modalities were effective in a community setting, more research is needed to investigate whether these treatments are also applicable in primary care. TRIAL REGISTRATION: PROSPERO CRD42016038442
แแฐแแแ แแแฅแแแแก (แแแแแจแแแแ) แกแแคแแแแ แกแแคแแ แฐแแแ แแแจแ
แคแแขแแก แแแแแฆแแแแก แแแ แแฆแ แฃแชแแแแแแแฐแแแ แแแฅแแ-แแแแแจแแแแ - แแฃแแขแฃแ แฃแแ แแแฆแแแฌแ แแฃแ แฅแแแจแ, แ แแแแแก แแแฆแแแฌแแแแ แแแแแ แแฃแแ แแงแ แแฃแ แฅแแแแก แฅแแ แแแแแแแแจแ แแ แแแแฃแแ แแแแแจแแแแแแแก แแแฆแแแซแแแแกแแแแ. แฅแแแแฅ แแแแแฅแแกแแ แแแ แกแแคแแ แแแฉแแแแ แจแ แแแแแแแ. แแแกแ แฌแแแแแ แแแ แแ แแแแแแก แแฎแ แแแแ แฌแแแแกแฃแแ แฅแแ แแแแแ แแฃแฐแแฏแแ แแแ แแงแแแแ. แแแฌแงแแแแแ แแแแแแแแแแก แแแฆแแแแก แจแแแแแ, แกแฌแแแแแแแ แแแแแ แจแ, 1955 แฌแแแก แแแฅแแ แฌแแแแ แแ แแแแแแก แแแแแแแแแก แกแแคแแ แฐแแแ แแแจแ แแชแฎแแแ แแ แแฃแฅแกแแ แแ แแฃแแแ. 1962 แฌแแแก แแแแแแแแ แ แกแขแแแแแแแก แฃแแแแแ แกแแขแแขแแก แแ แฅแแขแแฅแขแฃแ แฃแแ แคแแแฃแแขแแขแ แแ แแแกแแฎแแแ แฅแแ แแฃแ แกแแคแแ แฐแแแ แแแจแ, แกแแแแช แขแฃแ แแกแขแฃแแ แกแแแแแแแแแแ แแแแแ แกแ. แจแแแแแ แแ แฅแแขแแฅแขแแ แแแแช แแฃแจแแแแแ. แแฃแแชแ แแแกแ แแแแแแ แ แแแขแแชแแแ แแกแขแแ แแฃแแ แกแแแจแแแแแก, แฅแแ แแฃแแ แแแแก แจแแกแแฎแแ แชแแแแแแแก แจแแแ แแแแแ แแแฎแแ. แแแ แแแแแแจแ แแงแแคแ แจแแแแฎแแแแแ แจแแฎแแแ แฅแแ แแแแแแแก แแ แแแแแแ แแแแแ, แ แแ แแ แกแแแแแแ แฅแแ แแฃแแ แแแแแแ แแ แแ แแแแแ แจแแฅแแแแแ แแแแ แแแขแแ แแขแฃแ แ. แงแแแแแ แแกแแแ แจแแฎแแแแ แ แแฃ แแแคแแ แแแชแแ แแฐแแแแก แฃแคแ แ แแฆแแแแแแแแ แแ แแแขแแ แแกแก แฃแฆแแแแแแแ. แแฃแแขแฃแ แฃแแ แแแแจแแ แแก แแแแแ แแกแขแแ แแฃแ แกแแแจแแแแแกแแแ - แแก แแงแ แแแกแ แแแฆแแแฌแแแแแก แแแแแแ แ แแแแแแ. แแฃแ แฏแแแแก แแแแแแงแแคแแแแแแก แจแแแแ แฉแฃแแแแแกแ แแ แแแแฆแแแแแกแแแแแก แแแแ แจแ แแแ แแแกแฌแแ. 1968 แฌแแแก แแแ แแฃแ แฅแฃแ แแแแแ แแแแแญแแ แฌแแแแ โแแฃแ แฏแแกแขแแแ - แแฃแแขแฃแ แ, แฎแแแแแแแแ, แแแขแแ แแขแฃแ แ, แแกแขแแ แแ, แคแแแแแแ แ.โ แกแฌแแ แแ แแ แแแแแชแแแแ แจแแแขแงแ แฃแแแ แแแแ แแฃแ แฏแแ แแแแแกแ แฌแแ แแแแแแแแแ แแ แแกแขแแ แแฃแแ แกแแแจแแแแแก แแ แกแแแแแ. 980 แฌแแแก 5 แแแแแกแก แฅแแแแฅ แแฃแ แกแแจแ, แแฐแแแ แแแแแจแแแแ แแฃแ แฅแฃแแ แฃแแขแ แ-แแแชแแแแแแแกแขแฃแ แ แแแฏแแฃแคแแแแก โแ แฃแฎแ แแแแแแแกโ แแฅแขแแแแกแขแแแแ แแแแแแก. แแแแแจแแแแ แแแแ แแ แแซแแแแ แแแแญแ แ. แจแแแแแ แแแแแก แกแแฅแแแแแแแแก แแแกแ แจแแแแ - แแแแ แแ แแแแแจแแแแ แฉแแฃแแแ แกแแแแแแจแ. แแฐแแแ แแแฅแแ-แแแแแจแแแแ แกแแคแแ แฐแแแ แแแจแ แแแแแกแแแแแแก. แแแก แกแแคแแแแก แแฃแ แฅแฃแ แแ แฅแแ แแฃแ แแแแแ แแฌแแ แแ: โแแ แแแชแฎแแแ แ แฉแแแ แฎแแแฎแแกแแแแแก แแ แแ แ แฃแแแแแแแแแกแแแแแก
Effectiveness of an intervention to reduce sickness absence in patients with emotional distress or minor mental disorders: A randomized controlled effectiveness trial
OBJECTIVE: The purpose of this study was to evaluate the effectiveness of an activating intervention designed to reduce sick leave duration in patients with emotional distress or minor mental disorders. METHOD: In a 1.5-year randomized controlled trial, 194 patients with minor mental disorders received either an experimental intervention by social workers or general practitioners' usual care. The intervention focused on understanding causes, developing and implementing problem-solving strategies and promoting early work resumption. Outcome measures were sick leave duration, mental health and physical health (questionnaires included the Hospital Anxiety and Depression Scale, the Four-Dimensional Symptom Questionnaire and SF-36), all measured at baseline at and 3, 6 and 18 months later. Multilevel analyses were used to evaluate differences between groups. RESULTS: The groups did not differ significantly on any of the outcome measures, except that the experimental group reported higher satisfaction with treatment. CONCLUSION: Although the intervention has benefits, it was not successful at its primary goal (i.e., to reduce sick leave duration in patients with emotional distress or minor mental disorders). Programs aimed at the reduction of sick leave duration may yield better results if targeted at patients with more severe emotional problems than at those with exclusively emotional distress or minor mental disorders, or if delivered by caregivers who are closer to the work environment than are social workers, such as occupational physicians
Predicting return to work in employees sick-listed due to minor mental disorders.
Objective: To investigate which factors predict return to work (RTW) after 3 and 6 months in employees sick-listed due to minor mental disorders. Methods: Seventy GPs recruited 194 subjects at the start of sick leave due to minor mental disorders. At baseline (T0), 3 and 6 months later (T1 and T2, respectively), subjects received a questionnaire and were interviewed by telephone. Using multivariate logistic regression analyses, we developed three prediction models to predict RTW at T1 and T2. Results The RTW rates were 38% after 3 months (T1) and 61% after 6 months (T2). The main negative predictors of RTW at T1 were: (a) a duration of the problems of more than 3 months before sick leave; and (b) somatisation. The main negative predictors of RTW at T2 were: (a) a duration of the problems of more than 3 months before sick leave; (b) more than 3 weeks of sick leave before inclusion in the study; and (c) anxiety. The main negative predictors of RTW at T2 for those who had not resumed work at T1 were: (a) more than 3 weeks of sick leave before inclusion in the study; and (b) depression at T1. The predictive power of the models was moderate with AUC-values between 0.695 and 0.763. Conclusions: The main predictors of RTW were associated with the severity of the problems. A long duration of the problems before the occurrence of sick leave and a long duration of sick leave before seeking help predict a relatively small probability to RTW within 3โ6 months. High baseline somatisation and anxiety, and high depression after 3 months make the prospect even worse. Since these predictors are readily assessable with just a few questions and a symptom questionnaire, this opens the opportunity to select high-risk employees for a targeted intervention to prevent long-term absenteeism. (aut. ref.